Skip to main content
. Author manuscript; available in PMC: 2021 Mar 13.
Published in final edited form as: Mucosal Immunol. 2020 Jun 15;14(2):317–330. doi: 10.1038/s41385-020-0312-8

Figure 3. Direct effects of SCFAs on ILCs.

Figure 3.

(a) Activation of signaling molecules (Arf2, Stat3, Stat5 and rS6) in ILCs. Rag1−/− colonic LP cells were cultured for 4h with IL-7 and SCFAs, and phosphorylation of indicated molecules in Lin CD127+ CD90+ ILCs was assessed. (b) Effects of small molecule inhibitors of Gαi, PI3K, mTOR and MEK1/2 on SCFA-mediated ILC proliferation. Rag1−/− spleen cells were cultured in an ILC3 condition (IL-7, IL-23 and IL-1β) for 4 days with the inhibitors, and numbers of Lin CD90+ CD127+ ILCs were determined by flow cytometry. (c) Detection of membrane PIP3 in ILCs by expressing GFP-PHAkt. CD90+ ILCs were enriched with magnetic sorting and were transfected with a plasmid expressing GFP-PHAkt and activated for 16h with cytokines (IL-7, IL-1β and IL-23) and TSA (20 nM) followed by paraformaldehyde fixation and staining with anti-CD90 and DRAQ5 for confocal microscopy. (d) Ffar2-dependent phosphorylation of Atf2, Stat3, and Stat5 in ILCs. LI LP ILC3, isolated from WT and Ffar2−/− mice, were stained for phosphorylation of the molecules. Pooled data obtained from at least 3 different experiments (n=4-6) are shown. *Significant differences (p<0.05) between groups.